Gonzalez Rocio, Guillen Rocio, Rocha-Romero Andrés, Carvajal-Valdy Gabriel, Avendaño-Perez Leonel, Webber Katherine-R
Pain Medicine, Instituto Nacional de Cancerología, Mexico City, Mexico City, MEX.
Pain Medicine, Clinica Alive, Mexico City, MEX.
Cureus. 2024 Sep 10;16(9):e69135. doi: 10.7759/cureus.69135. eCollection 2024 Sep.
Assessment of breakthrough pain is essential for adequate management of cancer pain. The Breakthrough Pain Assessment Tool (BAT) has been proven to be a brief, multidimensional, and reliable questionnaire for the assessment of breakthrough cancer pain (BTCP). Currently, there are no validated instruments in Spanish that allow assessing BTCP.
The objective of this study was to validate the Breakthrough Pain Assessment Tool - Spanish (BAT-S) version of the BAT in adult patients with cancer.
The BAT-S was tested in a prospective observational study conducted in adult patients with cancer-related pain and treated in a comprehensive cancer center in Mexico. We conducted a forward-backward translation and cross-cultural equivalence test in the Spanish language. The psychometric properties in patients with cancer were assessed using factor analysis, reliability, and validity. To assess reliability, the Kappa test and the intra-class correlation coefficient were used. For consistency, Cronbach's alpha test was used.
Seventy patients participated in the study; 140 questionnaires were analyzed. The Spanish translation was well accepted by participants. Reliability was comprised between 0.746 for "use of analgesics" and 1.00 for "pain location." Thirteen of the 14 items had values above 0.8, and 12 above 0.9. Cronbach´s alpha coefficient was 0.7.
This study confirms that BAT-S is a valid and reliable questionnaire to assess breakthrough pain in Mexican patients with cancer. This newly validated tool may be used to facilitate clinical management of primarily Spanish-speaking patients with breakthrough cancer pain.
This study describes a prospective observational study to assess the validity and reliability of the Breakthrough Pain Assessment Tool in its Spanish version. The results support the use of this newly validated tool to facilitate clinical management of primarily Spanish-speaking patients with breakthrough cancer pain.
突破性疼痛评估对于癌症疼痛的充分管理至关重要。突破性疼痛评估工具（BAT）已被证明是一种用于评估癌症突破性疼痛（BTCP）的简短、多维度且可靠的问卷。目前，西班牙语中尚无经过验证的用于评估BTCP的工具。
本研究的目的是在成年癌症患者中验证BAT的西班牙语版突破性疼痛评估工具（BAT-S）。
在墨西哥一家综合癌症中心对患有癌症相关疼痛的成年患者进行的前瞻性观察研究中对BAT-S进行了测试。我们进行了西班牙语的前后翻译和跨文化等效性测试。使用因子分析、信度和效度评估癌症患者的心理测量特性。为评估信度，使用了Kappa检验和组内相关系数。为评估一致性，使用了Cronbach's alpha检验。
70名患者参与了研究；分析了140份问卷。西班牙语翻译被参与者很好地接受。信度在“使用镇痛药”的0.746至“疼痛部位”的1.00之间。14个项目中有13个的值高于0.8，12个高于0.9。Cronbach's alpha系数为0.7。
本研究证实BAT-S是一种用于评估墨西哥癌症患者突破性疼痛的有效且可靠的问卷。这一最新验证的工具可用于促进主要为西班牙语的患有癌症突破性疼痛患者的临床管理。
本研究描述了一项前瞻性观察研究，以评估突破性疼痛评估工具西班牙语版的有效性和可靠性。结果支持使用这一最新验证的工具来促进主要为西班牙语的患有癌症突破性疼痛患者的临床管理。
